VECTOR-BORNE DISEASES
Clinical trials for VECTOR-BORNE DISEASES explained in plain language.
Never miss a new study
Get alerted when new VECTOR-BORNE DISEASES trials appear
Sign up with your email to follow new studies for VECTOR-BORNE DISEASES, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Experimental malaria vaccine aims to block parasite growth
⭐️ VACCINE ⭐️ CompletedThis trial tests an experimental malaria vaccine called RH5.2-VLP, given with an adjuvant (Matrix-M) to boost the immune response. Healthy adults aged 18–45 receive three doses, and some volunteers are later exposed to malaria parasites in a controlled setting to see if the vacci…
Matched conditions: VECTOR-BORNE DISEASES
Phase: PHASE1, PHASE2 • Sponsor: University of Oxford • Aim: ⭐️ VACCINE ⭐️
Last updated Jul 22, 2026 00:00 UTC
-
New malaria drug put to the test in human trial
Knowledge-focused CompletedThis study tested a new experimental drug called MMV367 in 12 healthy adults. Participants were intentionally infected with a controlled, low-level malaria infection to see how well the drug works and how safe it is. The goal was to measure how the body processes the drug and how…
Matched conditions: VECTOR-BORNE DISEASES
Phase: PHASE1 • Sponsor: Medicines for Malaria Venture • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:03 UTC